Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2025-03-24 00:00:00 ET · period of report 2025-03-20 · accession 0001140361-25-010119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-24 | 2025-03-20 | ROIV | Humes Jennifer | CAO | A - Grant | $0.00 | +112.3K | 112.3K | New | $0 |
| D | 2025-03-24 | 2025-03-20 | ROIV | Humes Jennifer | CAO | A - Grant | $0.00 | +115.1K | 115.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-03-20 | A | A | 112,255 | $0.00 | 112,255 | D | — | — | (F1) Award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of March 20, 2025. These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter, subject to the reporting person's Continuous Service through each applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-03-20 | A | A | 115,108 | $0.00 | 115,108 | D | $10.97 · — to 2035-03-19 | 115,108 Common Shares | (F2) Award of stock options to purchase Common Shares with a vesting commencement date of February 20, 2025. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in thirty-six (36) successive equal monthly installments thereafter, subject to the reporting person's Continuous Service through each applicable vesting date. |